ABSTRACT
Consequences of SARS-CoV-2 infection on pregnant women and their descendants are not well known. The Mother and Child Covid-19 study is a cohort recruiting about 1000 pregnant women and their children in Cantabria, North of Spain, during COVID-19 pandemic. This article reports the cohort profile and preliminary results as recruitment is still open. Three sub-cohorts can be identified at recruitment. Sub-cohort 1 includes women giving birth between 23rd March and 25th May 2020; they have been retrospectively recruited and could have been exposed to COVID-19 only in their third trimester of pregnancy. Sub-cohort 2 includes women giving birth from 26th May 2020 on; they are being prospectively recruited and could have been exposed to COVID-19 in both their second and third trimesters of pregnancy. Sub-cohort 3 includes women in their 12th week of pregnancy prospectively recruited from 26th May 2020 on; they could have been exposed to COVID-19 anytime in their pregnancy. All women are being tested for SARS-CoV-2 infection using both RT-PCR for RNA detection and ELISA for anti-SARS-CoV-2 antibodies. All neonates are being tested for antibodies using immunochemoluminiscency tests; if the mother is tested positive for SARS-CoV-2 RNA, a naso-pharyngeal swab is also obtained from the child for RT-PCR analysis. Children will be followed-up for one year in order to ascertain the effect that COVID-19 on their development. As of 29thJuly, 477 women have been recruited (212, 132 and 133 for sub-cohorts 1, 2 and 3, respectively). Eight women tested positive to SARS-CoV-2 RNA. Seven children were born from these women and all tested negative for SARS-CoV-2 RNA. Summarizing, we are recruiting a cohort of 1000 pregnant women and their neonates during the COVID-19 pandemic. Results so far show that few women were infected at delivery and no child have been affected.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is funding by a grant from Instituto de Salud Carlos III (ISCIII) (reference: COV20/00923). The funder did not have any role in the design, methods, analysis, or preparation of this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Clinical Research Ethics Committee of Cantabria (reference: 2020.174).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are available upon request
